GANX 1.74 ▼ -9.38% Live Trading Data - Stocknear

Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.74
-0.18 (-9.38%)
At close: Sep 04, 2025, 3:59 PM
1.78
2.26%
After-hours: Sep 04, 2025, 07:58 PM EDT
-9.38%
Bid 1.74
Market Cap 62.55M
Revenue (ttm) 82.24K
Net Income (ttm) -18.59M
EPS (ttm) -0.59
PE Ratio (ttm) -2.95
Forward PE -2.56
Analyst Buy
Ask 1.83
Volume 2,158,595
Avg. Volume (20D) 338,167
Open 1.95
Previous Close 1.92
Day's Range 1.55 - 1.95
52-Week Range 1.00 - 3.19
Beta 0.14

About GANX

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GANX
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for GANX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
10 months ago
+14.68%
Gain Therapeutics shares are trading higher after ... Unlock content with Pro Subscription
11 months ago
+17.03%
Gain Therapeutics shares are trading higher after the company announced the presentation of new evidence supporting the disease-modifying activity of Gt-02287 in preclinical animal models of both GBA-1 and idiopathic Parkinson's disease.